{"timestamp": 1771602810.0092485, "value": {"ticker": "PLX", "company_name": "Protalix BioTherapeutics, Inc.", "short_name": "Protalix BioTherapeutics, Inc. ", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 251316192, "float_shares": 71926292, "shares_outstanding": 80421181, "short_ratio": 4.42, "short_percent_of_float": 0.053400002, "shares_short": 4116458, "shares_short_prior": 4211881, "insider_percent_held": 0.10154, "institution_percent_held": 0.18742001, "total_cash": 29370000, "total_debt": 8177000, "total_revenue": 61840000, "revenue_growth": -0.006, "earnings_growth": -0.01, "profit_margins": 0.08723, "gross_margins": 0.57536, "operating_margins": 0.11938, "debt_to_equity": 15.455, "current_ratio": 3.03, "book_value": 0.659, "price_to_book": 4.7420335, "operating_cashflow": -10032000, "free_cashflow": -13410375, "price": 3.125, "52w_high": 3.15, "52w_low": 1.32, "avg_volume": 964946, "avg_volume_10d": 2191770, "full_time_employees": 213, "audit_risk": 8, "overall_risk": 6}}